Dell Technologies Capital and Intel Capital are set to exit the audio enhancement technology provider, which has agreed to be bought by Cisco.

The Telefónica subsidiary has bought cyber risk consultancy and software producer Govertis having previously invested through subsidiary ElevenPaths.

Alibaba's financial services spinoff has officially filed for a dual listing in Shanghai and Hong Kong that could potentially raise $30bn.

The Sompo, Fujitsu and Relx-backed data miner, which has raised some $2.7bn in venture funding, has chosen the New York Stock Exchange to list its shares.

University of Utah autism diagnosis service provider Lineagen has been snapped up in a transaction worth at least $9.6m in cash, stocks and liabilities.

Yumanity Therapeutics will take over Nasdaq-listed Proteostasis in a reverse merger after raising more than $100m from investors including Biogen, Merck & Co, Pfizer and Sanofi.

UT Dallas spinout Cersci Therapeutics has been acquired in a deal potentially worth nearly $940m, including a $52.5m upfront payment.

Gastrointestinal and liver disease-focused Metacrine has filed to go public having raised $125m from investors including Eli Lilly.

Hyatt, Sotheby’s, Digital Garage, American Express and Advance Publications exited experience marketplace IfOnly in an acquistion by fellow investor Mastercard in January.

CRM forecasting software provider Node has been purchased having raised $37m from investors including MS&AD Insurance, Gree, Recruit and JetBlue.